EVALUATING R&D PREMIUM IN THE INDIAN HEALTH AND PHARMACEUTICALS INDUSTRIES
The economic advantages of research and development (R&D) investment have shown conflicting results in empirical studies. This study aimed to examine a different approach, evaluating R&D premium and cross-sectional variability of equity returns, a particular case for the Indian healthcare i...
Main Authors: | Bhumiswor Sharma, Srikanth Pyati |
---|---|
Format: | Article |
Language: | English |
Published: |
Petra Christian University
2022-10-01
|
Series: | Jurnal Manajemen dan Wirausaha |
Subjects: | |
Online Access: | https://jurnalmanajemen.petra.ac.id/index.php/man/article/view/25022 |
Similar Items
-
The Value Premium in Capital Asset Pricing; the Case of Tehran Stock Exchange
by: محمداسماعیل فدائینژاد, et al.
Published: (2006-12-01) -
The value premium in the Vietnamese equity market
by: Le Quy Duong
Published: (2024-02-01) -
The value and accounting premium for South African-listed shares
by: Jürgen Ernstberger, et al.
Published: (2008-10-01) -
Inclusion of debt claims in asset pricing models: Evidence from the CDS Index
by: Lijing Du, et al.
Published: (2023-05-01) -
Risk premiums in life insurance
by: Elinor Mualem, et al.
Published: (2019-01-01)